Gingerol

Last updated
Gingerol
Gingerol.png
Names
Preferred IUPAC name
(5S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one
Other names
[6]-Gingerol; 6-Gingerol
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.131.126 OOjs UI icon edit-ltr-progressive.svg
KEGG
PubChem CID
UNII
  • InChI=1S/C17H26O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h8,10-11,14,18,20H,3-7,9,12H2,1-2H3/t14-/m0/s1 Yes check.svgY
    Key: NLDDIKRKFXEWBK-AWEZNQCLSA-N Yes check.svgY
  • InChI=1/C17H26O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h8,10-11,14,18,20H,3-7,9,12H2,1-2H3/t14-/m0/s1
    Key: NLDDIKRKFXEWBK-AWEZNQCLBF
  • O=C(C[C@@H](O)CCCCC)CCc1cc(OC)c(O)cc1
Properties
C17H26O4
Molar mass 294.38 g/mol
Melting point 30 to 32 °C (86 to 90 °F; 303 to 305 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)
Gingerol
HeatVery hot (chemical)
Scoville scale 60,000 SHU

Gingerol ([6]-gingerol) is a phenolic phytochemical compound found in fresh ginger that activates heat receptors on the tongue. [1] [2] It is normally found as a pungent yellow oil in the ginger rhizome, but can also form a low-melting crystalline solid. This chemical compound is found in all members of the Zingiberaceae family and is high in concentrations in the grains of paradise as well as an African Ginger species.

Contents

Cooking ginger transforms gingerol via a reverse aldol reaction into zingerone, which is less pungent and has a spicy-sweet aroma. When ginger is dried or mildly heated, gingerol undergoes a dehydration reaction forming shogaols, which are about twice as pungent as gingerol. [3] This explains why dried ginger is more pungent than fresh ginger. [4]

Ginger also contains [8]-gingerol, [10]-gingerol, [5] and [12]-gingerol, [6] collectively deemed gingerols.

Physiological potential

In a pre-clinical meta-analysis of gingerol compounds anticancer, anti-inflammatory, anti-fungal, [7] antioxidant, neuroprotective [8] and gastroprotective properties were reported, which include studies in-vitro and in-vivo . [9] A few in-vivo studies have proposed that gingerols facilitate healthy glucose regulation for diabetics. [10] [11] [12] Many studies have been around the effects of gingerols on a wide range of cancers including leukemia, [13] prostate, [14] breast, [15] skin, [16] ovarian, [17] lung, [18] pancreatic [19] and colorectal. [20] There has not been much clinical testing to observe gingerols physiological impacts in humans. [21] [22]

While many of the chemical mechanisms associated with the effects of gingerols on cells have been thoroughly studied, few have been in a clinical setting. This is due to the high variability in natural phytochemicals and the lack of efficacy in research. [21] [23] Most herbal medicine, which include gingerols, are under the restrictions of the Food and Drug Administration in the United States and experimental methods have not held up to scrutiny which has decreased the value in phytochemical research. [23] [21] Herbal medicine is untested for quality assurance, potency and effectiveness in clinical settings due to a lack of funding in eastern medical research. [21] Most research on [6]-Gingerol has been on either mouse subjects (in-vivo) or on cultured human tissue (in-vitro) and may be used in the future to discuss possible applications for multi-target disease control.

An investigation scrutinizing gingerol's anti-fungal capabilities remarked that an African species of ginger tested higher in both gingerol and shogaol compounds than the more commonly cultivated Indonesian relative. [7] When tested for the anti-fungal properties the African ginger combated against 13 human pathogens and was three times more effective than the commercial Indonesian counterpart. [7] It is thought that gingerol compounds work in tandem with the other phytochemicals present including shogaols, paradols and zingerone. [7]

A few established cellular pathways effected by [6]-gingerol that result in apoptosis of a cancerous cell. ABBREVIATIONS: CDK: Cyclin-dependent kinase; PI3K: Phosphoinositide 3-kinase; Akt: Protein kinase B; mTOR: Mammalian target of rapamycin; AMPK: 5'adenosine monophosphate-activated protein kinase; Bax: Bcl-2-associated X protein; Bcl-2: B-cell lymphoma 2. Gingerol cytotoxic activity.jpg
A few established cellular pathways effected by [6]-gingerol that result in apoptosis of a cancerous cell. ABBREVIATIONS: CDK: Cyclin-dependent kinase; PI3K: Phosphoinositide 3-kinase; Akt: Protein kinase B; mTOR: Mammalian target of rapamycin; AMPK: 5’adenosine monophosphate-activated protein kinase; Bax: Bcl-2-associated X protein; Bcl-2: B-cell lymphoma 2.

In a meta analysis looking at many different phytochemical effects on prostate cancer, two specific studies using mice observed [6]-gingerol compounds induced apoptosis in cancer cells by interfering with the mitochondrial membrane. [14] There were also observed mechanisms associated with the disruption of G1 phase proteins to stop the reproduction of cancer cells which is also an associated benefit of other relevant anticancer studies. [14] [20] [17] [19] The main mechanism by which gingerol phytochemicals act on cancer cells seems to be protein disruption. The anti-carcinogenic activity of [6]-gingerol and [6]-paradol was analysed in a study observing the cellular mechanisms associated with mouse skin cancer which targeted the activator proteins associated with tumor initiation. Gingerol compounds inhibited the transformation of normal cells into cancer cells by blocking AP-1 proteins and when cancer did develop paradol encouraged apoptosis due to its cytotoxic activity. [16] [13] [6]-Gingerol exhibits cell cycle arrest capabilities, apoptotic action and enzyme-coupled cell signaling receptor degradation in cancer cells. Gingerol has been observed to stop proliferation through inhibiting the translation of Cyclin proteins necessary for replication during G1 and G2 phase of cell division. [24] To promote apoptosis in cancer cells Cytochrome C is ejected from the mitochondria which ceases ATP production leaving a dysfunctional mitochondria. The Cytochrome C assembles an apoptosome which activates the Caspase-9 and initiates an executioner Caspase cascade, effectively breaking down DNA into histones and promoting apoptosis. [6]-Gingerol also inhibits the anti-apoptotic Bcl-2 proteins on the surface of mitochondria, which in turn increases the capabilities for the pro-apoptotic Bcl-2 proteins to initiate cell death. Cancer cells exhibit high amounts of growth hormone activator proteins that are expressed through enzyme-coupled signaling pathways. By halting the phosphorylation of PI-3-Kinase the Akt protein cannot bind with its PH domain, effectively deactivating the downstream signal. Successively keeping Bad proteins bound to anti-apoptotic proteins which keeps them from promoting cell growth, consequently, a double negative cellular signaling pathway to promote apoptosis.

Cultured human breast cancer cells were subjected to various concentrations of [6]-gingerol to determine the impacts on live cells. These concentration dependent results concluded that there was no impact at 5 μM but a reduction of 16% occurred at 10 μM. [15] [6]-gingerol targeted three specific proteins in breast cancer cells that promote metastasis and while adhesion remained relatively unchanged, [6]-gingerol inhibited the cancer cells from invading and increasing in size. [15] This study suggests the mechanism by which cancer cell growth was impacted was due to a reduction in specific mRNA that transcribes for extracellular degrading enzymes called matrix metalloproteinases (MMP's). [15] An examination using human cells in-vitro displayed gingerols capabilities in combating oxidative stress. The results concluded that gingerol had anti-inflammatory effects though shogaol showed the most promising effects combating free radicals. [22] There was an inverted dose- concentration response and as dosage concentration increased the amount of free radicals in cells decreased. [22]

Cisplatin is a chemotherapy drug that if used in high dosages causes renal failure which is considered a limiting factor for this life saving drug. By using [6]-gingerol it prevented the occurrence of renal failure in rats. [25] [6]-gingerol improved glutathione production in dose-dependent results which suggested that the higher a dosage the more of an effect [6]-gingerol had. [25]

Gingerol compounds are thought to help in diabetic patients because of increases in glutathione, a cellular toxin regulatory factor. [11] Anti-hyperglycaemic effects were studied in diabetic and severely obese mice. Gingerol compounds increased glucose uptake in cells without the need of a synthetic insulin activator, while also decreasing fasting glucose and increasing glucose tolerance. [10] In a different study the exact metabolic mechanisms associated with the physiological benefits of gingerol phytochemicals concluded that there was increased enzyme activity (CAT) and glutathione production while decreasing lipoprotein cholesterol and improving glucose tolerance in mice. [11] Cardio-arrhythmia is a common side effect of diabetic patients and the anti-inflammatory effects of gingerol suppressed the risks by lowering blood glucose levels in-vivo. [12]

The anti-oxidant properties of [6]-gingerol has been considered as a defense against Alzheimer’s. A study observed the molecular mechanisms responsible for the protection against DNA fragmentation and mitochondrial membrane potential deterioration of cells which suggests a neuroprotective support of gingerol. [8] This study indicates that ginger up-regulates glutathione production in cells, including nerve cells, through anti-oxidative properties which decreases the risk of Alzheimer's in human neuroblastoma cells and mouse hippocampal cells. [8]

While many studies suggest the low risk of using ginger phytochemicals to combat oxidation damage to cells, there are a few studies that suggest potential genotoxic effects. In one study too high of a dose to human hepatoma cells resulted in DNA fragmentation, chromosomal damage and organelle membrane instability which could result in apoptotic behavior. [26] There are some pro-oxidant behaviors to gingerol compounds when the concentration reaches high levels although also considered, in normal conditions these phytochemicals observed have anti-inflammatory and anti-oxidant qualities. [26] In another study [6]-Gingerol notably inhibited the metabolic rate of rats when given an intraperitoneal injection which induced a hypothermic reaction though, when consumed orally in excess there were no changes in body temperature. [27]

Biosynthesis

Proposed gingerol biosynthesis Proposed Gingerol Biosynthesis Pathway.svg
Proposed gingerol biosynthesis

Both ginger (Zingiber officinale) and turmeric (Curcuma longa) had been suspected to utilize phenylpropanoid pathway and produce putative type III polyketide synthase products based on the research of 6-gingerol biosynthesis by Denniff and Whiting in 1976 [28] and by Schröder's research in 1997. [29] 6-Gingerol is the major gingerol in ginger rhizomes and it possesses some interesting pharmacological activities like analgesic effect. While the biosynthesis of 6-gingerol is not fully elucidated, plausible pathways are presented here.

Alternative proposed pathway Proposed Gingerol Biosynthesis Alt. Pathway.svg
Alternative proposed pathway

In the proposed biosynthetic pathway, Scheme 1, L-Phe (1) is used as the starting material. It is converted into Cinnamic acid (2) via phenylalanine ammonia lyase (PAL). Then it is turned into p-Coumaric acid (3) with use of cinnamate 4-hydroxylase (C4H). 4-coumarate:CoA ligase (4CL) is then used to get p-Coumaroyl-CoA (5). P-Coumaroyl shikimate transferase (CST) is the enzyme that is responsible for the bonding of shikimic acid and p-Coumaroyl-CoA. The complexed (5) is then selectively oxidized at C3 by p-coumaroyl 5-O-shikimate 3'-hydroxylase (CS3'H) to alcohol. With another action of CST, shikimate is broken off from this intermediate, thereby yielding Caffeoyl-CoA (7). In order to get desired substitution pattern on the aromatic ring, caffeoyl-CoA O-methyltransferase (CCOMT) converts the hydroxyl group at C3 into methoxy as seen in Feruloyl-CoA (8). Up until this step, according to Ramirez-Ahumada et al., the enzyme activities are very active. [30] It is speculated that some polyketide synthases (PKS) and reductases are involved in final synthesis of 6-Gingerol (10).

Because it is unclear whether the methoxy group addition is performed before or after the condensation step of the polyketide synthase, alternative pathway is shown in Scheme 2, where methoxy group is introduced after PKS activity. In this alternative pathway, the enzymes involved are likely to be cytochrome p450 hydroxylases, and S-adenosyl-L-methionine-dependent O-methyltransferases (OMT). [30] There are three possibilities for the reduction step by Reductase: directly after PKS activity, after PKS and Hydroxylase activity, or in the end after PKS, Hydroxylase, and OMT activity.

Related Research Articles

<span class="mw-page-title-main">Apoptosis</span> Programmed cell death in multicellular organisms

Apoptosis is a form of programmed cell death that occurs in multicellular organisms and in some eukaryotic, single-celled microorganisms such as yeast. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, DNA fragmentation, and mRNA decay. The average adult human loses between 50 and 70 billion cells each day due to apoptosis. For an average human child between eight and fourteen years old, each day the approximate loss is 20 to 30 billion cells.

<span class="mw-page-title-main">Necrosis</span> Unprogrammed cell death caused by external cell injury

Necrosis is a form of cell injury which results in the premature death of cells in living tissue by autolysis. The term "necrosis" came about in the mid-19th century and is commonly attributed to German pathologist Rudolf Virchow, who is often regarded as one of the founders of modern pathology. Necrosis is caused by factors external to the cell or tissue, such as infection, or trauma which result in the unregulated digestion of cell components. In contrast, apoptosis is a naturally occurring programmed and targeted cause of cellular death. While apoptosis often provides beneficial effects to the organism, necrosis is almost always detrimental and can be fatal.

<span class="mw-page-title-main">Ginger</span> Species of plant used as a spice

Ginger is a flowering plant whose rhizome, ginger root or ginger, is widely used as a spice and a folk medicine. It is a herbaceous perennial which grows annual pseudostems about one meter tall, bearing narrow leaf blades. The inflorescences bear flowers having pale yellow petals with purple edges, and arise directly from the rhizome on separate shoots.

<span class="mw-page-title-main">GSK-3</span> Class of enzymes

Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition of phosphate molecules onto serine and threonine amino acid residues. First discovered in 1980 as a regulatory kinase for its namesake, glycogen synthase (GS), GSK-3 has since been identified as a protein kinase for over 100 different proteins in a variety of different pathways. In mammals, including humans, GSK-3 exists in two isozymes encoded by two homologous genes GSK-3α (GSK3A) and GSK-3β (GSK3B). GSK-3 has been the subject of much research since it has been implicated in a number of diseases, including type 2 diabetes, Alzheimer's disease, inflammation, cancer, addiction and bipolar disorder.

<span class="mw-page-title-main">Quercetin</span> Chemical compound

Quercetin is a plant flavonol from the flavonoid group of polyphenols. It is found in many fruits, vegetables, leaves, seeds, and grains; capers, red onions, and kale are common foods containing appreciable amounts of it. It has a bitter flavor and is used as an ingredient in dietary supplements, beverages, and foods.

<span class="mw-page-title-main">Fas ligand</span> Protein-coding gene in the species Homo sapiens

Fas ligand is a type-II transmembrane protein expressed on cytotoxic T lymphocytes and natural killer (NK) cells. Its binding with Fas receptor (FasR) induces programmed cell death in the FasR-carrying target cell. Fas ligand/receptor interactions play an important role in the regulation of the immune system and the progression of cancer.

Casein kinase 2 (CK2/CSNK2) is a serine/threonine-selective protein kinase that has been implicated in cell cycle control, DNA repair, regulation of the circadian rhythm, and other cellular processes. De-regulation of CK2 has been linked to tumorigenesis as a potential protection mechanism for mutated cells. Proper CK2 function is necessary for survival of cells as no knockout models have been successfully generated.

<span class="mw-page-title-main">Fas receptor</span> Protein found in humans

The Fas receptor, also known as Fas, FasR, apoptosis antigen 1, cluster of differentiation 95 (CD95) or tumor necrosis factor receptor superfamily member 6 (TNFRSF6), is a protein that in humans is encoded by the FAS gene. Fas was first identified using a monoclonal antibody generated by immunizing mice with the FS-7 cell line. Thus, the name Fas is derived from FS-7-associated surface antigen.

p53 upregulated modulator of apoptosis Protein-coding gene in the species Homo sapiens

The p53 upregulated modulator of apoptosis (PUMA) also known as Bcl-2-binding component 3 (BBC3), is a pro-apoptotic protein, member of the Bcl-2 protein family. In humans, the Bcl-2-binding component 3 protein is encoded by the BBC3 gene. The expression of PUMA is regulated by the tumor suppressor p53. PUMA is involved in p53-dependent and -independent apoptosis induced by a variety of signals, and is regulated by transcription factors, not by post-translational modifications. After activation, PUMA interacts with antiapoptotic Bcl-2 family members, thus freeing Bax and/or Bak which are then able to signal apoptosis to the mitochondria. Following mitochondrial dysfunction, the caspase cascade is activated ultimately leading to cell death.

The unfolded protein response (UPR) is a cellular stress response related to the endoplasmic reticulum (ER) stress. It has been found to be conserved between mammalian species, as well as yeast and worm organisms.

<span class="mw-page-title-main">Paradol</span> Chemical compound

Paradol is the active flavor constituent of the seeds of Guinea pepper. It is also found in ginger. Paradol has been found to have antioxidant and antitumor promoting effects in a mouse model.

<span class="mw-page-title-main">Shogaol</span> Chemical compound

Shogaols are pungent constituents of ginger similar in chemical structure to gingerol. The most common of the group is [6]-shogaol. Like zingerone, it is produced when ginger is dried or cooked. Moreover, shogaol are converted to other constituents when heat is applied over time, which is why ginger loses its spiciness as it is cooked.

<span class="mw-page-title-main">DNA damage-inducible transcript 3</span> Human protein and coding gene

DNA damage-inducible transcript 3, also known as C/EBP homologous protein (CHOP), is a pro-apoptotic transcription factor that is encoded by the DDIT3 gene. It is a member of the CCAAT/enhancer-binding protein (C/EBP) family of DNA-binding transcription factors. The protein functions as a dominant-negative inhibitor by forming heterodimers with other C/EBP members, preventing their DNA binding activity. The protein is implicated in adipogenesis and erythropoiesis and has an important role in the cell's stress response.

<span class="mw-page-title-main">ADP/ATP translocase 4</span> Protein-coding gene in the species Homo sapiens

ADP/ATP translocase 4 (ANT4) is an enzyme that in humans is encoded by the SLC25A31 gene on chromosome 4. This enzyme inhibits apoptosis by catalyzing ADP/ATP exchange across the mitochondrial membranes and regulating membrane potential. In particular, ANT4 is essential to spermatogenesis, as it imports ATP into sperm mitochondria to support their development and survival. Outside this role, the SLC25AC31 gene has not been implicated in any human disease.

<span class="mw-page-title-main">Fisetin</span> Chemical compound

Fisetin (7,3′,4′-flavon-3-ol) is a plant flavonol from the flavonoid group of polyphenols. It can be found in many plants, where it serves as a yellow/ochre colouring agent. It is also found in many fruits and vegetables, such as strawberries, apples, persimmons, onions and cucumbers. Its chemical formula was first described by Austrian chemist Josef Herzig in 1891.

Tumstatin is a protein fragment cleaved from collagen that serves as both an antiangiogenic and proapoptotic agent. It has similar function to canstatin, endostatin, restin, and arresten, which also affect angiogenesis. Angiogenesis is the growth of new blood vessels from pre-existing blood vessels, and is important in tumor growth and metastasis. Angiogenesis is stimulated by many growth factors, the most prevalent of which is vascular endothelial growth factor (VEGF).

<span class="mw-page-title-main">Necroptosis</span> Programmed form of necrosis, or inflammatory cell death

Necroptosis is a programmed form of necrosis, or inflammatory cell death. Conventionally, necrosis is associated with unprogrammed cell death resulting from cellular damage or infiltration by pathogens, in contrast to orderly, programmed cell death via apoptosis. The discovery of necroptosis showed that cells can execute necrosis in a programmed fashion and that apoptosis is not always the preferred form of cell death. Furthermore, the immunogenic nature of necroptosis favors its participation in certain circumstances, such as aiding in defence against pathogens by the immune system. Necroptosis is well defined as a viral defense mechanism, allowing the cell to undergo "cellular suicide" in a caspase-independent fashion in the presence of viral caspase inhibitors to restrict virus replication. In addition to being a response to disease, necroptosis has also been characterized as a component of inflammatory diseases such as Crohn's disease, pancreatitis, and myocardial infarction.

<span class="mw-page-title-main">ADP/ATP translocase 2</span> Protein-coding gene in humans

ADP/ATP translocase 2 is a protein that in humans is encoded by the SLC25A5 gene on the X chromosome.

Curcumin synthase categorizes three enzyme isoforms, type III polyketide synthases (PKSs) present in the leaves and rhizome of the turmeric plant that synthesize curcumin. CURS1-3 are responsible for the hydrolysis of feruloyldiketide-CoA, previously produced in the curcuminoid pathway, and a decarboxylative condensation reaction that together comprise one of the final steps in the synthesis pathway for curcumin, demethoxycurcumin, and bisdemethoxycurcumin, the compounds that give turmeric both its distinctive yellow color, and traditional medical benefits. CURS should not be confused with Curcuminoid Synthase (CUS), which catalyzes the one-pot synthesis of bisdemethoxycurcumin in Oryza sativa.

<span class="mw-page-title-main">Paraptosis</span> Type of programmed cell death distinct from apoptosis and necrosis

Paraptosis is a type of programmed cell death, morphologically distinct from apoptosis and necrosis. The defining features of paraptosis are cytoplasmic vacuolation, independent of caspase activation and inhibition, and lack of apoptotic morphology. Paraptosis lacks several of the hallmark characteristics of apoptosis, such as membrane blebbing, chromatin condensation, and nuclear fragmentation. Like apoptosis and other types of programmed cell death, the cell is involved in causing its own death, and gene expression is required. This is in contrast to necrosis, which is non-programmed cell death that results from injury to the cell.

References

  1. ↑ Mao QQ, Xu XY, Cao SY, Gan RY, Corke H, Beta T, Li HB (May 2019). "Zingiber officinale Roscoe)". Foods. 8 (6): 185. doi: 10.3390/foods8060185 . PMC   6616534 . PMID   31151279.
  2. ↑ Yin, et al. (17 June 2019). "Structural mechanisms underlying activation of TRPV1 channels by pungent compounds in gingers". British Journal of Pharmacology. 176 (17): 3364–3377. doi:10.1111/bph.14766. PMC   6692589 . PMID   31207668.
  3. ↑ NSF International Determination of Gingerols and Shogaols in Zingiber officinale rhizome and powdered extract by High-Performance Liquid Chromatography[ full citation needed ]
  4. ↑ McGee, Harold (2004). "A survey of tropical spices". McGee on Food and Cooking. Hodder and Stoughton. p. 426. ISBN   0-340-83149-9.
  5. ↑ Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, et al. (August 2008). "Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects". Cancer Epidemiology, Biomarkers & Prevention. 17 (8): 1930–6. doi:10.1158/1055-9965.EPI-07-2934. PMC   2676573 . PMID   18708382.
  6. ↑ Park M, Bae J, Lee DS (November 2008). "Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria". Phytotherapy Research. 22 (11): 1446–9. doi:10.1002/ptr.2473. PMID   18814211. S2CID   31384218.
  7. 1 2 3 4 Ficker C, Smith ML, Akpagana K, Gbeassor M, Zhang J, Durst T, et al. (September 2003). "Bioassay-guided isolation and identification of antifungal compounds from ginger". Phytotherapy Research. 17 (8): 897–902. doi:10.1002/ptr.1335. PMID   13680820. S2CID   4141252.
  8. 1 2 3 Lee C, Park GH, Kim CY, Jang JH (June 2011). "[6]-Gingerol attenuates β-amyloid-induced oxidative cell death via fortifying cellular antioxidant defense system". Food and Chemical Toxicology. 49 (6): 1261–9. doi:10.1016/j.fct.2011.03.005. PMID   21396424.
  9. ↑ Baliga MS, Haniadka R, Pereira MM, D'Souza JJ, Pallaty PL, Bhat HP, Popuri S (July 2011). "Update on the chemopreventive effects of ginger and its phytochemicals". Critical Reviews in Food Science and Nutrition. 51 (6): 499–523. doi:10.1080/10408391003698669. PMID   21929329. S2CID   45531427.
  10. 1 2 Son MJ, Miura Y, Yagasaki K (August 2015). "Mechanisms for antidiabetic effect of gingerol in cultured cells and obese diabetic model mice". Cytotechnology. 67 (4): 641–52. doi:10.1007/s10616-014-9730-3. PMC   4474985 . PMID   24794903.
  11. 1 2 3 Tamrakar AK, Singh AB, Srivastava AK (February 2009). "db/+ Mice as an alternate model in antidiabetic drug discovery research". Archives of Medical Research. 40 (2): 73–8. doi:10.1016/j.arcmed.2008.12.001. PMID   19237015.
  12. 1 2 El-Bassossy HM, Elberry AA, Ghareib SA, Azhar A, Banjar ZM, Watson ML (September 2016). "Cardioprotection by 6-gingerol in diabetic rats". Biochemical and Biophysical Research Communications. 477 (4): 908–914. doi:10.1016/j.bbrc.2016.06.157. PMID   27378426. S2CID   205946473.
  13. 1 2 Wei QY, Ma JP, Cai YJ, Yang L, Liu ZL (November 2005). "Cytotoxic and apoptotic activities of diarylheptanoids and gingerol-related compounds from the rhizome of Chinese ginger". Journal of Ethnopharmacology. 102 (2): 177–84. doi:10.1016/j.jep.2005.05.043. PMID   16024193.
  14. 1 2 3 Salehi B, Fokou PV, Yamthe LR, Tali BT, Adetunji CO, Rahavian A, et al. (June 2019). "Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents". Nutrients. 11 (7): 1483. doi: 10.3390/nu11071483 . PMC   6683070 . PMID   31261861.
  15. 1 2 3 4 Lee HS, Seo EY, Kang NE, Kim WK (May 2008). "[6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells". The Journal of Nutritional Biochemistry. 19 (5): 313–9. doi:10.1016/j.jnutbio.2007.05.008. PMID   17683926.
  16. 1 2 Bode AM, Ma WY, Surh YJ, Dong Z (February 2001). "Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol". Cancer Research. 61 (3): 850–3. PMID   11221868.
  17. 1 2 Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, Liu JR (December 2007). "Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells". BMC Complementary and Alternative Medicine. 7 (1): 44. doi: 10.1186/1472-6882-7-44 . PMC   2241638 . PMID   18096028.
  18. ↑ Semwal RB, Semwal DK, Combrinck S, Viljoen AM (September 2015). "Gingerols and shogaols: Important nutraceutical principles from ginger". Phytochemistry. 117: 554–568. doi:10.1016/j.phytochem.2015.07.012. PMID   26228533.
  19. 1 2 Park YJ, Wen J, Bang S, Park SW, Song SY (October 2006). "[6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells". Yonsei Medical Journal. 47 (5): 688–97. doi:10.3349/ymj.2006.47.5.688. PMC   2687755 . PMID   17066513.
  20. 1 2 Lee SH, Cekanova M, Baek SJ (March 2008). "Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells". Molecular Carcinogenesis. 47 (3): 197–208. doi:10.1002/mc.20374. PMC   2430145 . PMID   18058799.
  21. 1 2 3 4 Betz JM, Brown PN, Roman MC (January 2011). "Accuracy, precision, and reliability of chemical measurements in natural products research". Fitoterapia. Papers from the 2010 DSHEA Symposium, Chicago, Il, USA. 82 (1): 44–52. doi:10.1016/j.fitote.2010.09.011. PMC   3026088 . PMID   20884340.
  22. 1 2 3 Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN (February 2010). "Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol". Journal of Ethnopharmacology. 127 (2): 515–20. doi:10.1016/j.jep.2009.10.004. PMID   19833188.
  23. 1 2 Pelkonen O, Xu Q, Fan TP (January 2014). "Why is Research on Herbal Medicinal Products Important and How Can We Improve Its Quality?". Journal of Traditional and Complementary Medicine. 4 (1): 1–7. doi: 10.4103/2225-4110.124323 . PMC   4032837 . PMID   24872927.
  24. ↑ Mao, Qian-Qian; Xu, Xiao-Yu; Cao, Shi-Yu; Gan, Ren-You; Corke, Harold; Beta, Trust; Li, Hua-Bin (June 2019). "Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe)". Foods. 8 (6): 185. doi: 10.3390/foods8060185 . PMC   6616534 . PMID   31151279.
  25. 1 2 Kuhad A, Tirkey N, Pilkhwal S, Chopra K (2006). "6-Gingerol prevents cisplatin-induced acute renal failure in rats". BioFactors. 26 (3): 189–200. doi:10.1002/biof.5520260304. PMID   16971750. S2CID   21531335.
  26. 1 2 Yang G, Zhong L, Jiang L, Geng C, Cao J, Sun X, Ma Y (April 2010). "Genotoxic effect of 6-gingerol on human hepatoma G2 cells". Chemico-Biological Interactions. 185 (1): 12–7. doi:10.1016/j.cbi.2010.02.017. PMID   20167213.
  27. ↑ Ueki S, Miyoshi M, Shido O, Hasegawa J, Watanabe T (April 2008). "Systemic administration of [6]-gingerol, a pungent constituent of ginger, induces hypothermia in rats via an inhibitory effect on metabolic rate". European Journal of Pharmacology. 584 (1): 87–92. doi:10.1016/j.ejphar.2008.01.031. PMID   18295202.
  28. ↑ Denniff, Phillip; Whiting, Donald A. (1976). "Biosynthesis of [6]-gingerol, pungent principle of Zingiber officinale". Journal of the Chemical Society, Chemical Communications (18): 711. doi:10.1039/C39760000711.
  29. ↑ Schröder, Joachim (1997). "A family of plant-specific polyketide synthases: facts and predictions". Trends in Plant Science. 2 (10): 373–378. doi:10.1016/S1360-1385(97)87121-X.
  30. 1 2 Ramirez-Ahumada M, Timmermann BN, Gang DR (September 2006). "Biosynthesis of curcuminoids and gingerols in turmeric (Curcuma longa) and ginger (Zingiber officinale): identification of curcuminoid synthase and hydroxycinnamoyl-CoA thioesterases". Phytochemistry. 67 (18): 2017–29. doi:10.1016/j.phytochem.2006.06.028. PMID   16890967.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.